AKY-56197-56608
4 vaccinations
3 coded responses
29 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 462 / IN
- Registered
- 2021-01-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-03
Registered in v-safe
-
2021-01-03
Dose 1 — Pfizer-BioNTech
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-17
-
2021-01-24
Dose 2 — Pfizer-BioNTech
- 2021-01-24
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-07
- 2021-02-14
- 2021-02-21
- 2021-02-28
- 2021-03-07
- 2021-04-25
-
2021-07-25
Survey response — 6 months, dose 2MedDRA: Ear infection, Ear pain, SARS-CoV-2 test negative — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Ear pain, low grade temperature 99.6 > diagnosed with ear infection, COVID negativeMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-25
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-03
-
2021-10-02
Dose 3 — Pfizer-BioNTech
-
2022-01-24
Survey response — 12 months, dose 2MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Congestion and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-01-24
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-25
-
2022-09-30
Dose 4 — Pfizer-BioNTech
- 2022-10-11
- 2022-11-06
- 2022-11-13
- 2023-01-01
-
2023-03-31
Survey response — 6 months, dose 4MedDRA: Abortion spontaneous — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-03 | Pfizer-BioNTech | |
| 2 | 2021-01-24 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
| 4 | 2022-09-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-25 | Unsuccessful | |
| 2022-01-24 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: Ear pain, low grade temperature 99.6 > diagnosed with ear infection, COVID negative
Release 11 — 12 months, dose 2
Symptoms: Congestion and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Ear infection | ✓ | · | ✓ |
| SD | Ear pain | ✓ | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release